Prolonged Reduction of High Blood Pressure With Human Nitric Oxide Synthase Gene Delivery

Hypertension

Volumn 30, Issue 3, 1997, Pages 307-313

  Lin, Kuei Fu ^a   Chao, Lee ^a   Chao, Julie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC GMP; NITRIC OXIDE SYNTHASE; PLASMID DNA;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; GENE THERAPY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM;

ANIMALS; ARGININE; BLOOD PRESSURE; CATTLE; CELL LINE; CYCLIC GMP; CYTOMEGALOVIRUS; DNA; ENDOTHELIUM, VASCULAR; GENE THERAPY; HUMANS; HYPERTENSION; MALE; NITRIC OXIDE SYNTHASE; PROMOTER REGIONS (GENETICS); PULMONARY ARTERY; RATS; RATS, INBRED SHR; TIME FACTORS; TRANSFECTION;

EID: 0030793748     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.30.3.307     Document Type: Article

References (42)

1. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
2. Leone AM, Palmer RMJ, Knowles RG, Francis PL, Ashton DS, Moncada S. Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline. J Biol Chem. 1991;266:23790-23795.
3. G -Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate the blood pressure in vivo? Biochem Biophys Res Commun. 1989;160:881-886.
4. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
5. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175-195.
6. Hull AD, White CR, Pearce WJ. Endothelium-derived relaxing factor and cyclic GMP-dependent vasorelaxation in human chorionic plate arteries. Placenta. 1994;15:365-375.
7. Ignarro LJ, Buga GM, Wood KS, Byrnes RE, Chaudburi G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
8. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
9. Nava E, Llinas MT, Gonzalez JD, Salazar FJ. Nitric oxide synthase activity in renal cortex and medulla of normotensive and spontaneously hypertensive rats. Am J Hypertens. 1996;9:1236-1239.
10. Ikeda Y, Saito K, Kim J-I, Yokoyama M. Nitric oxide synthase isoform activities in kidney of Dahl salt-sensitive rats. Hypertension. 1995;26:1030-1034.
11. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R. L-Arginine-induced hypotension. Lancet. 1990;336:696. Letter.
12. Matsuoka H, Nakata M, Kohno K, Koga Y, Nomura G, Toshima H, Imaizumi T. Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension. 1996;27:14-18.
13. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
14. Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. Role of L-arginine-nitric oxide pathway in hypertension. J Hypertens. 1993;11:639-645.
15. Arnal JF, Amrani AI, Chatellier G, Menard J, Michel JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
16. Numaguchi K, Egashima K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension. 1995;26;957-962.
17. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995:92:1137-1141.
18. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995;270:319-324.
19. Brooker G, Harper JF, Terasaki WL, Moylan RD. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res. 1979;10:1-33.
20. Harper JF, Brooker G. Femtomole-sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res. 1975:1:207-218.
21. Gettys TW, Okonogi K, Tarry WC, Johnston J, Horton C, Taylor IL. Examination of relative rates of cAMP synthesis and degradation in crude membranes of adipocytes treated with hormones. Second Messengers Phosphoproteins. 1990;13:37-50.
22. Gettys TW, Ramkumar V, Uhing RJ, Seger L, Taylor IL. Alterations in mRNA levels, expression, and function of GTP-binding regulatory proteins in adipocytes from obese mice (C57BL/6J-ob/ob). J Biol Chem. 1991;266:15949-15959.
23. Lin KF, Chao J, Chao L. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension. 1995;26:847-853.
24. Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 1994;23:236-243.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
26. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
27. Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J Clin Invest. 1995;95:1710-1716.
28. Xiong W, Chao J, Chao L. Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension. 1995;25:1-5.
29. Chao J, Jin L, Chen LM, Chen VC, Chao L. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hum Gene Ther. 1996;7:901-911.
30. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682-685.
31. Gold ME, Bush PA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun. 1989;164:714-721.
32. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon-gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst. 1990;82:772-776.
33. Luscher TF, Haefeli WE. L-Arginine in the clinical arena: tool or remedy? Circulation. 1993;87:1746-1748.
34. Hasegawa T, Takagi S, Nishimaki K, Morita K, Nakajima S. Impairment of L-arginine metabolism in spontaneously hypertensive rats. Biochem Int. 1992;26:653-658.
35. Kuo JF, Davis CW, Tse J. Depressed cardiac cyclic GMP-dependent protein kinase in spontaneously hypertensive rats and its further depression by guanethidine. Nature. 1976;261:335-336.
36. Stier CT Jr, Sim GJ, Levine S. Dietary arginine fails to protect against cerebrovascular damage in stroke-prone hypertensive rats. Brain Res. 1991;549:354-356.
37. Unger T, Rettig R. Development of genetic hypertension: Is there a 'critical phase'? Hypertension. 1990;16:615-616.
38. Flotte TR. Prospects for virus-based gene therapy for cystic fibrosis. J Bioenerg Biomembr. 1993;25:37-42.
39. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465-1468.
40. Barr E, Leiden JM. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science. 1991;254:1507-1509.
41. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science. 1991;254:1509-1512.
42. Chen L-M, Chao L, Chao J. Adenoviral-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats. Hum Gene Ther. 1997;8:341-347.